Galectin Therapeutics Inc

NASDAQ:GALT   3:59:54 PM EDT
3.96
+0.21 (+5.60%)
Earnings Announcements

Galectin Therapeutics Reports Quarterly Loss Per Share Of $0.15

Published: 08/16/2021 13:16 GMT
Galectin Therapeutics Inc (GALT) - Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2021, and Provides Business Update.
Quarterly Loss per Share $0.15.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.13

More details on our Analysts Page.